www.positron.com
Positron Corporation offers innovative solutions through the production and distribution of molecular
imaging systems and radiopharmaceutical technologies.
Positron's automated radiopharmaceutical system readies for commercial deployment
Positron Corp (OTCBB: POSC) said Monday that its automated radiopharmaceutical system, PosiRx, has met the test standards required to be commercially distributed.
The Indianapolis-based molecular imaging company, which specializes in the field of nuclear cardiology, has developed a system that automates and simplifies the dose preparation and dispensing processes for radiopharmaceutical agents used in molecular imaging.
Radiopharmaceuticals, which feature radioactive isotopes, are used in the field of nuclear medicine as tracers in the diagnosis and treatment of many diseases.
Following internal testing of its new system, Positron retained the services of the University of New Mexico to assist in developing tests and validation protocols.
Last month, the company said it installed a PosiRx Beta system at the university, and recently, the system successfully completed testing of key criteria, including air quality, ensuring proper radiochemical purity of kits, product sterility, and dose accuracy, among others.


















